Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001601485-21-000060)

Filing Details

Accession Number:: 0001601485-21-000060
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-10-15 16:10:01
Reporting Period:: 2021-10-14

Accepted Time:: 2021-10-15 16:10:01
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1601485	Angion Biomedica Corp.	ANGN	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1568249	J Jennifer Rhodes	C/O Angion Biomedica Corp. 51 Charles Lindbergh Blvd. Uniondale NY 11553	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-10-14	430	$8.65	31,283	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The shares reported in this Form 4 were sold pursuant to a 10b5-1 trading plan adopted by the reporting person solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs") granted by the Issuer.